Evidence map›Paper›PMID 28264080›Full record

Trial reportJAMA2017

Effect of an Integrated Pest Management Intervention on Asthma Symptoms Among Mouse-Sensitized Children and Adolescents With Asthma: A Randomized Clinical Trial.

Elizabeth C Matsui, Matthew Perzanowski, Roger D Peng, Robert A Wise, Susan Balcer-Whaley, Michelle Newman, Amparito Cunningham, Adnan Divjan, Mary E Bollinger, Shuyan Zhai and 3 more

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in JAMA, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01251224 (Mouse Allergen and Asthma Intervention Trial), which is not on this map. Cited by 61 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 1 pooled it
9.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01251224 phase3completednot on this map

Mouse Allergen and Asthma Intervention Trial

TypeinterventionalSponsorJohns Hopkins UniversityRan2010 to 2016Enrolled361ConditionsAsthma, Mouse Allergy, Mouse Allergen ExposureArmsIntegrated Pest Management, Education
3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 1 synthesis or guideline pooled it, 111 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Childhood asthma and household exposures to nitrogen dioxide and fine particles: a triple-crossover randomized intervention trial.The Journal of asthma : official journal of the Association for the Care of Asthma · 2023
    Trial
  4. Trial
  5. Patterns and predictors of air purifier adherence in children with asthma living in low-income, urban households.The Journal of asthma : official journal of the Association for the Care of Asthma · 2022
    Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Validation of the maximum symptom day among children with asthma.The Journal of allergy and clinical immunology · 2019
    Trial
  11. Trial
  12. Article
  13. Effective pest control alone reduces mouse allergens in low-income housing.The journal of allergy and clinical immunology. Global · 2025
    Article
  14. Indoor Allergen Interventions in Homes and Schools for Managing Asthma.The journal of allergy and clinical immunology. In practice · 2025
    Review
  15. Article
  16. Review
  17. Article
  18. Minimizing Indoor Allergen Exposure: What Works?Current allergy and asthma reports · 2024
    Review
  19. Understanding Health Equity in Patient-Reported Outcomes.The journal of allergy and clinical immunology. In practice · 2024
    Review
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 1 country.

Elizabeth C MatsuiDivision of Pediatric Allergy/Immunology, School of Medicine, Johns Hopkins University, Baltimore, Maryland.
Matthew PerzanowskiDepartment of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, New York.
Roger D PengDepartment of Biostatistics, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland.
Robert A WiseDivision of Pulmonary and Critical Care Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland.
Susan Balcer-WhaleyDivision of Pediatric Allergy/Immunology, School of Medicine, Johns Hopkins University, Baltimore, Maryland.
Michelle NewmanDivision of Pediatric Allergy/Immunology, School of Medicine, Johns Hopkins University, Baltimore, Maryland.
Amparito CunninghamDivision of Pediatric Allergy/Immunology, Boston Children's Hospital, Harvard University Medical School, Boston, Massachusetts.
Adnan DivjanDepartment of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, New York.
Mary E BollingerDivision of Pulmonary, Allergy, and Immunology, School of Medicine, University of Maryland, Baltimore.
Shuyan ZhaiDivision of Pediatric Allergy/Immunology, School of Medicine, Johns Hopkins University, Baltimore, Maryland.
Ginger ChewDepartment of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, New York.
Rachel L MillerDepartment of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, New York7Division of Pulmonary, Allergy, and Critical Care Medicine, College of Physicians and Surgeons, Columbia University, New York, New York8Division of Pediatric Allergy, Immunology, and Rheumatology, College of Physicians and Surgeons, Columbia University, New York, New York.
Wanda PhipatanakulDivision of Pediatric Allergy/Immunology, Boston Children's Hospital, Harvard University Medical School, Boston, Massachusetts.
Johns Hopkins Medicine · USColumbia University · USBoston Children's Hospital · USHarvard University · USJohns Hopkins University · USUniversity of Maryland, Baltimore · US

Funding

True Metal fac coreP30ES009089 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MATTHEW S PERZANOWSKI · 1998 to 2026
$44.7M
Mouse Allergen and Asthma Intervention TrialU01AI083238 · NIAID · JOHNS HOPKINS UNIVERSITY · PI MATSUI, ELIZABETH C. · 2010 to 2014
$7.9M
The effect of a housing mobility program on environmental exposures and asthma morbidity among low-income minority childrenR01ES026170 · NIEHS · JOHNS HOPKINS UNIVERSITY · PI KEET, CORINNE, MATSUI, ELIZABETH C. · 2016 to 2025
$6.8M
Environmental Control as Add-on Therapy in Urban Children with AsthmaR01ES023447 · NIEHS · JOHNS HOPKINS UNIVERSITY · PI MATSUI, ELIZABETH C. · 2014 to 2018
$3.4M
Mouse Allergen and Inner-City AsthmaR01AI070630 · NIAID · JOHNS HOPKINS UNIVERSITY · PI MATSUI, ELIZABETH C. · 2006 to 2010
$1.9M
Midcareer Investigator Award: Urban School Allergen Exposures and Childhood AsthmK24AI106822 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI PHIPATANAKUL, WANDA · 2013 to 2022
$1.9M
Mentoring in Patient-Oriented Research on Asthma and the Indoor EnvironmentK24AI114769 · NIAID · UNIVERSITY OF TEXAS AT AUSTIN · PI MATSUI, ELIZABETH C. · 2015 to 2023
$1.6M
Mouse Allergen and Asthma Intervention TrialR34AI074928 · NIAID · JOHNS HOPKINS UNIVERSITY · PI MATSUI, ELIZABETH C. · 2007 to 2007
$197k
NIAID NIH HHS K24 AI106822NIAID NIH HHS K24 AI114769NIAID NIH HHS R01 AI070630NIAID NIH HHS R34 AI074928NIAID NIH HHS U01 AI083238NIEHS NIH HHS P30 ES009089NIEHS NIH HHS R01 ES023447NIEHS NIH HHS R01 ES026170
6 · The paper itself

Abstract

Importance: Professionally delivered integrated pest management (IPM) interventions can reduce home mouse allergen concentrations, but whether they reduce asthma morbidity among mouse-sensitized and exposed children and adolescents is unknown. Objective: To determine the effect of an IPM intervention on asthma morbidity among mouse-sensitized and exposed children and adolescents with asthma. Design, Setting, and Participants: Randomized clinical trial conducted in Baltimore, Maryland, and Boston, Massachusetts. Participants were mouse-sensitized and exposed children and adolescents (aged 5-17 years) with asthma randomized to receive professionally delivered IPM plus pest management education or pest management education alone. Enrollment occurred between May 2010 and August 2014; the final follow-up visit occurred on September 25, 2015. Interventions: Integrated pest management consisted of application of rodenticide, sealing of holes that could serve as entry points for mice, trap placement, targeted cleaning, allergen-proof mattress and pillow encasements, and portable air purifiers. Infestation was assessed every 3 months, and if infestation persisted or recurred, additional treatments were delivered. All participants received pest management education, which consisted of written material and demonstration of the materials needed to set traps and seal holes. Main Outcomes and Measures: The primary outcome was maximal symptom days defined as the highest number of days of symptoms in the previous 2 weeks among 3 types of symptoms (days of slowed activity due to asthma; number of nights of waking with asthma symptoms; and days of coughing, wheezing, or chest tightness) across 6, 9, and 12 months. Results: Of 361 children and adolescents who were randomized (mean [SD] age, 9.8 [3.2] years; 38% female; 181 in IPM plus pest management education group and 180 in pest management education alone group), 334 were included in the primary analysis. For the primary outcome, there was no statistically significant between-group difference for maximal symptom days across 6, 9, and 12 months with a median of 2.0 (interquartile range, 0.7-4.7) maximal symptom days in the IPM plus pest management education group and 2.7 (interquartile range, 1.3-5.0) maximal symptom days in the pest management education alone group (P = .16) and a ratio of symptom frequencies of 0.86 (95% CI, 0.69-1.06). Conclusions and Relevance: Among mouse-sensitized and exposed children and adolescents with asthma, an intensive year-long integrated pest management intervention plus pest management education vs pest management education alone resulted in no significant difference in maximal symptom days from 6 to 12 months. Trial Registration: clinicaltrials.gov Identifier: NCT01251224.

Indexed as

MiceRodenticidesAdolescentAllergensAnimalsAsthmaBaltimoreBedding and LinensBostonChildChild, PreschoolDustEnvironmental ExposureFemaleHumansMaleAllergensDustRodenticides

Identifiers

PMID28264080
PMCPMC5632564
OpenAlexW2591577397

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.